Value of serum CA-125 concentrations as predictors of pregnancy in assisted reproduction cycles

Human Reproduction

Volumn 16, Issue 6, 2001, Pages 1129-1134

  Tavmergen, Erol ^a   Sendag, Fatih ^a   Goker, Ege Nazan Tavmergen ^a   Levi, Rafael ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Assisted reproduction treatments; CA 125; Endometrium; Pregnancy; Receptivity

Indexed keywords

CA 125 ANTIGEN; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; HYALURONIDASE; PREGNYL 500; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UROFOLLITROPIN;

ACCURACY; ADULT; ARTICLE; ASSAY; CHEMOLUMINESCENCE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE MARKER; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; MENSTRUAL CYCLE; OOCYTE TRANSPORT; PERIPHERAL CIRCULATION; PREDICTION; PREGNANCY; PREGNANCY RATE; PREGNANCY TEST; PROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034969674     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.6.1129     Document Type: Article

References (34)

1. CA125 levels in human uterine fluid
2. Elevated serum concentrations of CA-125 in patients with advanced endometriosis
3. Contribution to the physiology and pathology of endometrial receptivity: The determination of protein patterns in human uterine secretions
4. Development of an endometrial explant model for the investigation of uterine readiness for implantation in the human
5. Serum pregnancy-specific beta1-glycoprotein before embryo transfer is related to endometrial thickness and to outcome prognosis in women undergoing in-vitro fertilization treatment
6. Technical evaluation of three second generation CA 125 assays
7. CA-125 concentrations in the serum and pregnancy outcome in IVF cycles
8. CA-125 secretion by luteal phase endometrium in vitro
9. Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients
10. CA-125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube
11. Prediction of outcome following transfer of in vitro fertilized human embryos by measurement of embryo associated suppressor factor
12. Explanation of the limited correlation between tumor CA-125 content and serum CA-125 antigen levels in patients with ovarian tumors
13. Endometrial thickness and growth during ovarian stimulation: A possible predictor of implantation in in vitro fertilization
14. Circulating CA125 levels in superovulated women are mainly derived from the ovaries
15. Immunohistochemical markers of uterine receptivity in the human endometrium
16. Immunopathologic characterizations of a monoclonal antibody that recognizes common surface antigen of human ovarian tumors of serous, endometrioid, and clear cell types
17. Tissue distribution of a coelomic epithelium related antigen recognized by the monoclonal antibody OC-125
18. Heterologous double-determinant immunoradiometric assay CA125. II: Reliable second-generation immunoassay for determining CA125 in serum
19. The second generation CA125 assay
20. Serum CA-125 levels do not depend on ovarian steroidogenesis
21. CA-125 levels in cervical mucus during the menstrual cycle
22. Evaluation of serum CA-125 concentrations as predictors of pregnancy with human in vitro fertilization
23. CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients
24. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities
25. Serum CA125 values on the day of oocyte retrieval are not predictive of subsequent pregnancy with in-vitro fertilization
26. Endometrial ultrasonography as a predictor of pregnancy in an in-vitro fertilization programme after ovarian stimulation and gonadotrophin-releasing hormone and gonadotrophins
27. Relationship between serum CA125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity
28. Factors affecting embryo implantation after human in vitro fertilization, a hypothesis
29. The use of CA-125 in the diagnosis and management of endometriosis
30. CA125 is an excretory product of human endometrial glands
31. The relationships between endometrial thickness, and blood flow and pregnancy rates in in-vitro fertilization
32. Tumor marker CA-125 in tissues of female reproductive tract and in serum during the normal menstrual cycle
33. Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125
34. Correlation between peripheral CA-125 levels and ovarian activity